JOJI KITAYAMA

Professor

Jichi Medical University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Joji Kitayama is a faculty member at Jichi Medical University in Japan. His research areas focus on advancements in intraperitoneal chemotherapy, the effects of preoperative conditions on cancer survival, and innovative drug delivery methods for solid tumors. His recent publications explore the implications of treatment timing and the role of metabolic factors in cancer outcomes.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Shin Saito

Jichi Medical University

JAPAN

View details

Naohiro Sata

Jichi Medical University

JAPAN

View details

Michiko Harao

Associate professor

Jichi Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

JOJI KITAYAMA

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Advances in Intraperitoneal Chemotherapy for Gastric Cancer Patients with Peritoneal Metastases: Current Status of Treatment and Institutional Insights

Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus

Optimizing Timing of Intraperitoneal Chemotherapy to Enhance Intravenous Carboplatin Concentration

Preoperative Bone Loss Predicts Decreased Survival Associated with Microvascular Invasion after Resection of Hepatocellular Carcinoma

Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review

Osteopenia Is Associated with Shorter Survival in Patients with Intrahepatic Cholangiocarcinoma

Remnant liver function is associated with long-term survival in patients with hepatocellular carcinoma undergoing hepatectomy

Novel Drug Delivery Method Targeting Para-Aortic Lymph Nodes by Retrograde Infusion of Paclitaxel into Pigs’ Thoracic Duct

Effect of Oral Administration of Lactiplantibacillus plantarum SNK12 on Temporary Stress in Adults: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study

Preoperative Osteopenia Is Associated with Significantly Shorter Survival in Patients with Perihilar Cholangiocarcinoma

ASO Author Reflections: Repeated Intraperitoneal Paclitaxel with Systemic Chemotherapy as the First-Line Treatment for Peritoneal Malignancy

Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases

Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus

Surgical Stress Increases Circulating Low-Density Neutrophils Which May Promote Tumor Recurrence

Exosomal microRNA in peritoneal fluid as a biomarker of peritoneal metastases from gastric cancer

Collaborators (3)

Shin Saito

Naohiro Sata

Michiko Harao

Make your next move.